These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28670345)

  • 61. A systematic review of free tissue transfer in the management of non-traumatic lower extremity wounds in patients with diabetes.
    Fitzgerald O'Connor EJ; Vesely M; Holt PJ; Jones KG; Thompson MM; Hinchliffe RJ
    Eur J Vasc Endovasc Surg; 2011 Mar; 41(3):391-9. PubMed ID: 21163675
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Guidelines for critical limb ischaemia and diabetic foot--introduction.
    Setacci C; Ricco JB;
    Eur J Vasc Endovasc Surg; 2011 Dec; 42 Suppl 2():S1-3. PubMed ID: 22172469
    [No Abstract]   [Full Text] [Related]  

  • 63. Growth factors for treating diabetic foot ulcers.
    Martí-Carvajal AJ; Gluud C; Nicola S; Simancas-Racines D; Reveiz L; Oliva P; Cedeño-Taborda J
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD008548. PubMed ID: 26509249
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Patient-centered clinical success after lower extremity revascularization for complex diabetic foot wounds treated in a multidisciplinary setting.
    Deery SE; Hicks CW; Canner JK; Lum YW; Black JH; Abularrage CJ
    J Vasc Surg; 2022 Apr; 75(4):1377-1384.e1. PubMed ID: 34921967
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Bypass Surgery Provides Better Outcomes Compared with Endovascular Therapy in the Composite Endpoint Comprising Relief from Rest Pain, Wound Healing, Limb Salvage, and Survival after Infra-inguinal Revascularisation in Patients with Chronic Limb Threatening Ischaemia.
    Morisaki K; Matsubara Y; Kurose S; Yoshino S; Furuyama T
    Eur J Vasc Endovasc Surg; 2022 Apr; 63(4):588-593. PubMed ID: 35221244
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Use of Nevelia Dermal-Epidermal Regenerative Template in the Management of Ischemic Diabetic Foot Postsurgical Wounds.
    Uccioli L; Meloni M; Izzo V; Giurato L
    Int J Low Extrem Wounds; 2020 Sep; 19(3):282-288. PubMed ID: 31996064
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Society for Vascular Surgery lower extremity threatened limb classification system based on Wound, Ischemia, and foot Infection (WIfI) correlates with risk of major amputation and time to wound healing.
    Zhan LX; Branco BC; Armstrong DG; Mills JL
    J Vasc Surg; 2015 Apr; 61(4):939-44. PubMed ID: 25656592
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Angiosome-directed revascularization for critical limb ischemia.
    McCallum JC; Lane JS
    Semin Vasc Surg; 2014 Mar; 27(1):32-7. PubMed ID: 25812757
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Autologous stem cell therapy in the treatment of limb ischaemia induced chronic tissue ulcers of diabetic foot patients.
    Kirana S; Stratmann B; Prante C; Prohaska W; Koerperich H; Lammers D; Gastens MH; Quast T; Negrean M; Stirban OA; Nandrean SG; Götting C; Minartz P; Kleesiek K; Tschoepe D
    Int J Clin Pract; 2012 Apr; 66(4):384-93. PubMed ID: 22284892
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The surgical history of the amputated limb according to the indication for revascularization: diabetic foot, acute ischaemia, aneurysmal disease, chronic arterial occlusive disease.
    Aerden D; Haentjens P; von Kemp K; Van den Bossche B; Staelens I; Debing E; Keymeulen B; Van den Brande P
    Acta Chir Belg; 2011; 111(6):384-8. PubMed ID: 22299326
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The use of fetal bovine acellular dermal matrix in severe diabetic foot ulceration and threatened limbs with tissue loss the use of FBADM as an adjunct for complex wounds.
    Gormley S; Hart O; French S; O'Shea C; Khashram M
    Vascular; 2024 Jun; 32(3):619-625. PubMed ID: 36415107
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Editor's Choice - Diabetic Limb Salvage With Endovascular Revascularisation and Free Tissue Transfer: Long-Term Follow up.
    Chang CH; Huang CC; Hsu H; Lin CM; Huang SM
    Eur J Vasc Endovasc Surg; 2019 Apr; 57(4):527-536. PubMed ID: 30910496
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Analysis of wound healing time and wound-free period as outcomes after surgical and endovascular revascularization for critical lower limb ischemia.
    Okazaki J; Matsuda D; Tanaka K; Ishida M; Kuma S; Morisaki K; Furuyama T; Maehara Y
    J Vasc Surg; 2018 Mar; 67(3):817-825. PubMed ID: 29032905
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Autologous cells derived from different sources and administered using different regimens for 'no-option' critical lower limb ischaemia patients.
    Abdul Wahid SF; Ismail NA; Wan Jamaludin WF; Muhamad NA; Abdul Hamid MKA; Harunarashid H; Lai NM
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010747. PubMed ID: 30155883
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Editor's Choice - The Prognostic Value of the WIfI Classification in Patients with Chronic Limb Threatening Ischaemia: A Systematic Review and Meta-Analysis.
    van Reijen NS; Ponchant K; Ubbink DT; Koelemay MJW
    Eur J Vasc Endovasc Surg; 2019 Sep; 58(3):362-371. PubMed ID: 31230866
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Outcomes of isolated inframalleolar interventions for chronic limb-threatening ischemia in diabetic patients.
    Cheun TJ; Jayakumar L; Sideman MJ; Pounds LC; Davies MG
    J Vasc Surg; 2020 May; 71(5):1644-1652.e2. PubMed ID: 32081478
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Strategies for free flap transfer and revascularisation with long-term outcome in the treatment of large diabetic foot lesions.
    Kallio M; Vikatmaa P; Kantonen I; Lepäntalo M; Venermo M; Tukiainen E
    Eur J Vasc Endovasc Surg; 2015 Aug; 50(2):223-30. PubMed ID: 26001322
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pedal arch patency and not direct-angiosome revascularization predicts outcomes of endovascular interventions in diabetic patients with critical limb ischemia.
    Troisi N; Turini F; Chisci E; Ercolini L; Frosini P; Lombardi R; Falciani F; Baggiore C; Anichini R; Michelagnoli S
    Int Angiol; 2017 Oct; 36(5):438-444. PubMed ID: 28541016
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effective wound bed preparation using maggot debridement therapy for patients with critical limb ischaemia.
    Nishijima A; Gosho M; Yoshida R; Yanagibayashi S; Takikawa M; Nishijima J; Sekido M; Yamamoto N
    J Wound Care; 2017 Aug; 26(8):483-489. PubMed ID: 28795888
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration.
    O'Meara S; Cullum N; Majid M; Sheldon T
    Health Technol Assess; 2000; 4(21):1-237. PubMed ID: 11074391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.